Topical medication interferes with face-down positioning after macular hole surgery

Acta Ophthalmologica Scandinavica

Volumn 81, Issue 3, 2003, Pages 226-229

  Krohn, Jørgen ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

Eye drops; Eye ointment; Face down positioning; Macular hole; Surgery; Topical medication

Indexed keywords

ANTIBIOTIC AGENT; CHLORAMPHENICOL; DEXAMETHASONE; EYE DROPS; EYE OINTMENT; HYDROCORTISONE; NETILMICIN; PREDNISOLONE; STEROID;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG INSTILLATION; FEMALE; GAS EXCHANGE; HEAD POSITION; HUMAN; MALE; PATIENT POSITIONING; POSTOPERATIVE CARE; PRIORITY JOURNAL; RETINA MACULA HOLE; STATISTICAL ANALYSIS; STEROID THERAPY; SURGICAL TECHNIQUE; TREATMENT OUTCOME; VITRECTOMY;

ADMINISTRATION, TOPICAL; ADULT; AGED; ANTI-BACTERIAL AGENTS; CHLORAMPHENICOL; DEXAMETHASONE; FEMALE; FLUOROCARBONS; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; OINTMENTS; OPHTHALMIC SOLUTIONS; POSTOPERATIVE CARE; PRONE POSITION; RETINAL PERFORATIONS; VISUAL ACUITY; VITRECTOMY; WOUND HEALING;

EID: 0038082041     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0420.2003.00075.x     Document Type: Article

References (11)

1. Demols P, Rasquin F&Schrooyen M (2000): Surgery for macular hole without positioning. Bull Soc Belge Ophthalmol 275: 57-61.
2. Funata M, Wendel RT, de la Cruz Z&Green WR (1992): Clinicopathologic study of bilateral macular holes treated with pars plana vitrectomy and gas tamponade. Retina 12: 289-298.
3. Gass JDM (1995): Reappraisal of biomicroscopic classification of stages of development of a macular hole. Am J Ophthalmol 119: 752-759.
4. Isomae T, Sato Y&Shimada H (2001): Shortening the duration of prone positioning after macular hole surgery - comparison between 1 week and 1 day. Nippon Ganka Gakkai Zasshi 105: 167-170.
5. Kelly NE&Wendel RT (1991): Vitreous surgery for idiopathic macular holes: results of a pilot study. Arch Ophthalmol 109: 654-659.
6. Lim SL&Dunbar MT (2000): Update on current surgical management of idiopathic macular holes. Clin Eye Vis Care 12: 51-60.
7. Schubert HD, Kuang K, Kang F, Head MW&Fischbarg J (1997): Macular holes: migratory gaps and vitreous as obstacles to glial closure. Graefes Arch Clin Exp Ophthalmol 235: 523-529.
8. Szurman P, Di Tizio FM, Lafaut B, Aisenbrey S, Grisanti S, Roters S&Bartz-Schmidt KU (2000): Stellenwert der postoperativen Positionierung in der Chirurgie des idiopathischen Makulaforamens - Kontrollierte konsekutive Studie. Klin Monatsbl Augenheilkd 217: 351-355.
9. Thompson JT, Glaser BM, Sjaarda RN, Murphy RP&Hanham A (1994): Effects of intraocular bubble duration in the treatment of macular holes by vitrectomy and transforming growth factor-beta 2. Ophthalmology 101: 1195-1200.
10. Thompson JT, Smiddy WE, Glaser BM, Sjaarda RN&Flynn HW (1996): Intraocular tamponade duration and success of macular hole surgery. Retina 16: 373-382.
11. Tornambe PE, Poliner LS&Grote K (1997): Macular hole surgery without face-down positioning. A pilot study. Retina 17: 179-185.